Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: A 12-year population-based cohort study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 6, 2013, Pages 717-723

  Wikstrom Shemer E ^a   Marschall, H U ^b   Ludvigsson, J F ^c,d   Stephansson, O ^c  

^a DANDERYD HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bile acids; gestational diabetes; intrahepatic cholestasis of pregnancy; intrauterine fetal death; obstetric cholestasis; pre eclampsia; stillbirth; ursodeoxycholic acid

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; COHORT ANALYSIS; DELIVERY; DISEASE ASSOCIATION; FEMALE; FETUS OUTCOME; HOSPITAL DISCHARGE; HUMAN; IATROGENIC DISEASE; INTRAHEPATIC CHOLESTASIS; LABOR INDUCTION; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; STILLBIRTH;

CHOLESTASIS, INTRAHEPATIC; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS; STILLBIRTH; SWEDEN;

EID: 84876127062     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12174     Document Type: Article

References (28)

1. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA,. Liver disease in pregnancy. Lancet 2010; 375: 594-605.
2. Lammert F, Marschall HU, Glantz A, Matern S,. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012-21.
3. Geenes V, Williamson C,. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049-66.
4. Glantz A, Marschall HU, Mattsson LA,. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40: 467-74.
5. Glantz A, Marschall HU, Lammert F, Mattsson LA,. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399-405.
6. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O,. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011; 343: d6309.
7. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B,. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-8.
8. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A,. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-67.
9. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R,. Pre-eclampsia. Lancet 2010; 376: 631-44.
10. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
11. Shaw D, Frohlich J, Wittmann BA, Willms M,. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 1982; 142: 621-5.
12. Kenyon AP, Piercy CN, Girling J, Williamson C, Tribe RM, Shennan AH,. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 2002; 109: 282-8.
13. Baliutaviciene D, Zubruviene N, Zalinkevicius R,. Pregnancy outcome in cases of intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2011; 112: 250-1.
14. Goulis DG, Walker IA, de Swiet M, Redman CW, Williamson C,. Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases. Hypertens Pregnancy 2004; 23: 19-27.
15. Atabey S, Duvan CI, Eren U, Turhan NO,. Intrahepatic cholestasis and eclampsia: a case report. Hypertens Pregnancy 2007; 26: 363-9.
16. Lo TK, Lau WL, Lam HS, Leung WC, Chin RK,. Obstetric cholestasis in Hong Kong-local experience with eight consecutive cases. Hong Kong Med J 2007; 13: 387-91.
17. Heinonen S, Kirkinen P,. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999; 94: 189-93.
18. Kaaja RJ, Greer IA,. Manifestations of chronic disease during pregnancy. JAMA 2005; 294: 2751-7.
19. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS,. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338: 147-52.
20. Reece EA, Leguizamon G, Wiznitzer A,. Gestational diabetes: the need for a common ground. Lancet 2009; 373: 1789-97.
21. Houten SM, Watanabe M, Auwerx J,. Endocrine functions of bile acids. EMBO J 2006; 25: 1419-25.
22. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K,. Targeting bile-acid signalling for metabolic diseases. Nat Rev 2008; 7: 678-93.
23. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 313: 1137-40.
24. Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 2010; 59: 1899-905.
25. Steiner C, Othman A, Saely CH, Rein P, Drexel H, von Eckardstein A, et al. Bile Acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus. PLoS ONE 2011; 6: e25006.
26. Reyes H, Sjovall J,. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000; 32: 94-106.
27. Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU,. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008; 47: 544-51.
28. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG,. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876-80.